Skip to main content
logo
Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
1.300
+0.005 (0.39%)
May 6, 2026, 5:35 PM CET

Vivoryon Therapeutics Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
38.50M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023-3.62M--
Dec 31, 2022---
Dec 31, 202110.76M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cabka185.23M
Ctac N.V.125.71M
Morefield Group101.04M
Ebusco Holding76.60M
Almunda Professionals27.55M
Value820.32M
New Amsterdam Invest18.47M
Arcona Property Fund8.29M
Revenue Rankings

Vivoryon Therapeutics News

More News